Loading clinical trials...
Loading clinical trials...
This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Nebraska
NCT05386108 · Breast Neoplasms, Brain Neoplasms, and more
NCT07390539 · Central Nervous System Neoplasms, Brain Tumor, and more
NCT01180881 · Brain Tumor, Central Nervous System Neoplasms
NCT05850377 · High Grade Glioma, Glioma, and more
NCT02692898 · Central Nervous System Neoplasms, Primary Brain Neoplasms, and more
Unversity of Nebraska Medical Center
Omaha, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions